Page 102 - 72_03

JESÚS PINTOR AN. R. ACAD. NAC. FARM.

(10) WILSON, S. and LIVI, G. P. (2000): A G protein-coupled receptor for UDP-
(11) glucose. J. Biol. Chem. 275: 10767-10771.
(12) NORTH, R. A. and SURPRENANT, A. (2000): Pharmacology of cloned P2X
(13) receptors. Annu. Rev. Pharmacol. Toxicol. 40: 563-580.
(14) PINTOR, J.; PERAL, A.; INFANTES, J. J. and HERNÁNDEZ, F. (1999): ATP and
(15) adenosine: the forgotten transmitters in the eye. Recent. Res Dev. Neurochem.
(16) 2: 157-169.
(17) PINTOR, J. (2000): Purinergic signalling in the eye. In: Burnstock, G., Sillito,
(18) A., editors. Nervous control of the eye. London: Harwood Academic
(19) Publishers. p. 171-210.
(20) MIRAS-PORTUGAL, M. T.; GUALIX, J.; MATEO, J.; DÍAZ-HERNÁNDEZ, M.; GÓMEZ-VI-
LLAFUERTES, R.; CASTRO, E. and PINTOR, J. (1999): Diadenosine polyphosphates,
(21) extracelullar function and catabolism. Progr. Brain. Res. 120: 397-409.
(22) PINTOR, J.; PERAL, A.; HOYLE, C. H. V.; REDICK, C., DOUGLASS, J.; SIMS, I. and
(23) YERXA, B. R. (2002a): Effects of diadenosine polyphosphates on tear secretion
(24) in New Zealand white rabbits. J. Pharmacol. Exp. Ther. 300: 291-297.
PINTOR, J.; CARRACEDO, G.; ALONSO, M. C.; BAUTISTA, A. and PERAL, A. (2002b):
Presence of diadenosine polyphosphates in human tears. Pflugers. Arch. Eur.
J. Physiol. 443: 432-436.
PERAL, A.; CARACEDO, G.; ACOSTA, M. C.; GALLAR, J. and PINTOR, J. (2006):
Increased levels of diadenosine polyphosphates in dry eye. Invest. Ophthalmol.
Vis Sci. 47: 4053-4058.
WILSON, P. D.; HOVATER, J. S.; CASEY, C. C.; FORTENBERRY, J. A. and SCHWIEBERT,
E. M. (1999): ATP release mechanisms in primary cultures of epithelia derived
from the cysts of polycystic kidneys. J. Am. Soc. Nephrol. 10: 218-229.
MITCHELL, C. H.; CARRE, D. A.; MCGLINN, A. M.; STONE, R. and CIVAN, M. M.
(1998): A release mechanism for stored ATP in ocular ciliary epithelial cells.
Proc Natl Acad Sci USA 95: 7174-7178.
LAZAROWSKI, E. R.; BOUCHER, R. C. and HARDEN, T. K. (2003): Mechanisms of
release of nucleotides and integration of their action as P2X- and P2Y-
receptor activating molecules. Mol. Pharmacol. 64: 785-795.
ABRAHAM, E. H.; PRAT, A. G., GERWECK, L.; SENEVERATNE, T.; ARCECI, R. J.;
KRAMER, R.; GUIDOTTI, C. and CANTIELLO, H. F. (1993): The multidrug resistance
(mdr1) gene product functions as an ATP channel. Proc. Natl. Acad. Sci. USA.
90: 312-316.
GOMES, P.; SRINIVAS, S. P.; DRIESSCHE, W. V.; VEREECKE, J. and HIMPENS, B.
(2005): ATP release through connexin hemichannels in corneal endotelial
cells. Invest. Ophthalmol. Vis. Sci. 46: 1208-1218.
YERXA, B. R.; ELENA, P. P.; CAILLAUD, T.; AMAR, T. and EVANS, R. (1999): INS365,
a P2Y2 receptor agonist increases Schirmer scores in albino rabbits. Invest.
Ophthalmol. Vis. Sci. 401: B723.
YERXA, B. R. (2001): Therapeutic use of nucleotides in respiratory and
ophthalmic diseases. Drug Dev. Res. 52: 196-201.
FUJIHARA, T.; MURAKAMI, T.; FUJITA, H.; NAKAMURA, M. and NAKATA, K. (2001):
Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a
rat dry eye model. Invest. Ophthalmol. Vis. Sci. 42: 96-100.

536